日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas

嵌合抗原受体 T 细胞靶向 B 细胞淋巴瘤中的 CD79b

Fuliang Chu, Jingjing Cao, Jingwei Liu, Haopeng Yang, Timothy J Davis, Shao-Qing Kuang, Xiaoyun Cheng, Zheng Zhang, Swathi Karri, Long T Vien, Laura Bover, Ryan Sun, Francisco Vega, Michael Green, Richard Eric Davis, Sattva S Neelapu

CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel

CD19 靶向逃避是使用 axicabtagene ciloleucel 治疗的大 B 细胞淋巴瘤复发的机制

Vicki Plaks, John M Rossi, Justin Chou, Linghua Wang, Soumya Poddar, Guangchun Han, Zixing Wang, Shao-Qing Kuang, Fuliang Chu, Richard E Davis, Francisco Vega, Zahid Bashir, Caron A Jacobson, Frederick L Locke, Patrick M Reagan, Scott J Rodig, Lazaros J Lekakis, Ian W Flinn, David B Miklos, Adrian B

Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells

绕过 STAT3 介导的转录调节因子 ID2 抑制可提高树突状细胞的抗肿瘤功效

Haiyan S Li, Chengwen Liu, Yichuan Xiao, Fuliang Chu, Xiaoxuan Liang, Weiyi Peng, Jianhua Hu, Sattva S Neelapu, Shao-Cong Sun, Patrick Hwu, Stephanie S Watowich

IL-15 enhances the antitumor effect of human antigen-specific CD8+ T cells by cellular senescence delay

IL-15 通过延缓细胞衰老增强人类抗原特异性 CD8+ T 细胞的抗肿瘤作用

Jinsheng Weng, Kelsey E Moriarty, Flavio Egidio Baio, Fuliang Chu, Sung-Doo Kim, Jin He, Zuliang Jie, Xiaoping Xie, Wencai Ma, Jianfei Qian, Liang Zhang, Jing Yang, Qing Yi, Sattva S Neelapu, Larry W Kwak

Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment

人类滤泡性淋巴瘤中滤泡辅助性T细胞与肿瘤细胞之间的相互作用促进肿瘤微环境中的免疫逃逸。

Seema Rawal ,Fuliang Chu, Min Zhang, Hyun Jun Park, Durga Nattamai, Shibichakravarthy Kannan, Rakesh Sharma, David Delgado, Tina Chou, Heather Y Lin, Veerabhadran Baladandayuthapani, Amber Luong, Francisco Vega, Nathan Fowler, Chen Dong, R Eric Davis, Sattva S Neelapu